Pallas Capital Advisors LLC acquired a new position in shares of Ventas, Inc. (NYSE:VTR – Free Report) in the second quarter, according to its most recent disclosure with the SEC. The firm acquired 96,841 shares of the real estate investment trust’s stock, valued at approximately $8,599,000.
Several other hedge funds and other institutional investors also recently modified their holdings of VTR. Deutsche Bank AG purchased a new stake in shares of Ventas during the second quarter worth approximately $451,822,000. Perigon Wealth Management LLC acquired a new stake in shares of Ventas during the second quarter worth $580,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Ventas in the 2nd quarter valued at $140,441,000. OneDigital Investment Advisors LLC purchased a new position in Ventas in the 2nd quarter valued at $446,000. Finally, Plato Investment Management Ltd acquired a new position in Ventas in the 2nd quarter valued at $538,000. 94.18% of the stock is currently owned by hedge funds and other institutional investors.
Ventas Trading Down 0.4%
Shares of VTR opened at $91.18 on Tuesday. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. The firm’s 50-day moving average is $90.68 and its two-hundred day moving average is $86.72. Ventas, Inc. has a twelve month low of $66.38 and a twelve month high of $101.60. The firm has a market capitalization of $46.77 billion, a P/E ratio of 168.85, a PEG ratio of 2.11 and a beta of 0.69.
Analyst Ratings Changes
A number of equities analysts have commented on the stock. JPMorgan Chase & Co. upped their price objective on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Monday, May 11th. Raymond James Financial began coverage on shares of Ventas in a report on Tuesday, June 16th. They issued an “outperform” rating and a $94.00 target price on the stock. UBS Group boosted their price target on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research note on Monday, May 4th. Cantor Fitzgerald increased their price target on shares of Ventas from $97.00 to $102.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $100.00 price objective on shares of Ventas in a research report on Tuesday, June 16th. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Ventas currently has a consensus rating of “Moderate Buy” and a consensus target price of $98.00.
Read Our Latest Stock Report on Ventas
Insiders Place Their Bets
In other news, Director Michael J. Embler acquired 2,500 shares of Ventas stock in a transaction that occurred on Wednesday, June 3rd. The stock was purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares in the company, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.53% of the stock is owned by insiders.
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Stories
- Five stocks we like better than Ventas
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
